• Email:
  • Password:
  • Remember Me
 
Lecture Hall General Diabetes | Treatment

Advances in the Treatment of Childhood Diabetes

Available Credits
CPME 0.75
ACPE 0.75
CEU 0.75

William Tamborlane
William Tamborlane, MD, FAAP, FACE
Director of the Childrens Diabetes Program
Yale Pediatrics
Yale School of Medicine
New Haven, CT
System Requirements Method of Participation Disclosure Information

This lecture by William V. Tamborlane, MD describes the special challenges in treating youth with type 1 diabetes mellitus (T1DM), especially with respect to achieving target blood glucose and glycosylated hemoglobin levels and minimizing the risk of severe hypoglycemia. The impact of recent advances in therapy, including rapid and long acting insulin analogs, insulin pumps and continuous glucose monitoring, on the management and clinical outcomes of children and adolescents with T1DM are discussed in detail. The potential for combining these advances towards the development of an artificial pancreas will be presented

Goal and Objective
After participating in this activity, the viewer should be better able to:
1. Understand the pathophysiology of pediatric diabetes.
2. Relate current insulin treatments in light of past methods.
3. Describe newer insulin pump therapies and new technologies such as continuous glucose monitoring systems.
4. Anticipate which children are candidates for insulin pump therapy.

Estimated time to complete this activity is 50 minutes.

Physicians, diabetes educators, and other health care professionals who treat patients with diabetes.
Accreditation and Designation of Credit
PODIATRY: The Ohio College of Podiatric Medicine(OCPM) is an approved sponsor of Continuing Podiatric Medical Education through the Council on Podiatric Medical Education (CPME).

The Ohio College of Podiatric Medicine credits this activity for 0.75 credit hour.

Release Date: 02/26/2007 Expiration Date: 12/30/2012
Peer Review: on 02/26/2007

PHARMACY: Nova Southeastern University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been approved for 0.75 contact hours of General Pharmacy Continuing Education. (Activity Number:0092-9999-09-101-H01-P This is a knowledge-based activity)

Release Date: 01/25/2010 Expiration Date: 09/30/2012
Peer Review: on 09/30/2009
Activity Number: 0092-9999-09-101-H01-P This is a knowledge-based activity

NURSING: Professional Education Services Group (PESG) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. PESG is awarding 0.75 contact hours for this activity.(Activity Number:10053)

Release Date: 08/30/2010 Expiration Date: 08/31/2012
Peer Review: on 07/31/2010
Activity Number: 10053

System Requirements
Advances in the Treatment of Childhood Diabetes
Top
A Pentium-III class computer with a minimum of 256MB of system RAM is required to view Online Internet lectures. While a 56Kbps dial-up connection is supported, a Cable or DSL broadband Internet is strongly recommended for optimal video playback. You will need an up-to-date web browser such as Internet Explorer, Mozilla Firefox, or the AOL browser with Java and JavaScript enabled. Some lectures require the use of Internet Explorer to run and will not run with other browsers. Lectures may require the use of helper applications or plug-ins to access the materials. For example, most online lectures/presentations require either Adobe Flash Player or Windows Media Player (both free). To be able to print completion certificates Adobe Acrobat Reader must be installed.
Method of Participation
Advances in the Treatment of Childhood Diabetes
Top
Complete the 4 steps to earn CE/CME credit:
  • Complete and submit the required pre-test
  • View Lecture
  • Complete and submit post-test and program evaluation. Credit will be issued with a passing score of 70% or better.
  • Click Print Certificate.
Disclosure Information
Advances in the Treatment of Childhood Diabetes
Top
It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any PRESENT e-Learning Systems sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts.
William Tamborlane, MD, FAAP, FACE William V Tamborlane, MD has disclosed that he has received Honorarium/Expenses from Medtronic Diabetes